Lista de obras - Raffaella Origa - Dominio Público Uruguay

A decisional algorithm to start iron chelation in patients with beta thalassemia

artículo científico publicado en 2014

A genetic score for the prediction of beta-thalassemia severity.

artículo científico publicado en 2014

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox

artículo científico publicado en 2014

Beta-thalassemia

artículo científico publicado en 2010

Cholelithiasis in thalassemia major

artículo científico publicado en 2008

Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes

artículo científico publicado en 2007

Complexity of the alpha-globin genotypes identified with thalassemia screening in Sardinia

artículo científico publicado en 2013

Current growth patterns in children and adolescents with thalassemia major

artículo científico publicado en 2016

Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study

artículo científico publicado en 2014

Deferasirox: pharmacokinetics and clinical experience ⬇️

artículo científico publicado el 19 de diciembre de 2011

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.

artículo científico

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia

artículo científico publicado en 2015

Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia

artículo científico publicado en 2017

Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen

artículo científico publicado en 2008

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

artículo científico publicado en 2015

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

artículo científico

Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.

artículo científico publicado en 2014

Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major

artículo científico publicado en 2008

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major

artículo científico publicado en 2013

Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis

scientific article published on 31 January 2019

Investigating the Alpha1 Nco I Mutation

artículo científico publicado en 2014

Liver iron concentrations and urinary hepcidin in beta-thalassemia

artículo científico publicado en 2007

Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment

artículo científico publicado en 2013

Natural history of hepatitis C in thalassemia major: a long-term prospective study

artículo científico publicado en 2013

New case of contiguous gene syndrome at chromosome 8p11.2p12

article

No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia

article

Once-daily oral deferasirox for the treatment of transfusional iron overload

scientific article published on 01 March 2008

Onset of cardiac iron loading in pediatric patients with thalassemia major.

artículo científico publicado en 2008

Osteoporosis in beta-thalassemia: Clinical and genetic aspects

artículo científico publicado en 2005

Pregnancy and beta-thalassemia: an Italian multicenter experience.

artículo científico publicado en 2009

Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study

artículo científico publicado en 2018

Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major

artículo científico publicado en 2005

Sudden cardiac failure in a β-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia

scientific article published on 01 March 2007

Thalassemia Major: Who Is Afraid of Serum Ferritin below 500 μg/l?

artículo científico publicado en 2015

Thalassemia major between liver and heart: Where we are now.

artículo científico publicado en 2015

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

artículo científico publicado en 2017

α-globin gene quadruplication and heterozygous β-thalassemia: a not so rare cause of thalassemia intermedia

artículo científico publicado en 2013

β-Thalassemia.

artículo científico publicado en 2016

Lista de obras de Raffaella Origa

A decisional algorithm to start iron chelation in patients with beta thalassemia

A genetic score for the prediction of beta-thalassemia severity.

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox

Beta-thalassemia

Cholelithiasis in thalassemia major

Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes

Complexity of the alpha-globin genotypes identified with thalassemia screening in Sardinia

Current growth patterns in children and adolescents with thalassemia major

Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study

Deferasirox: pharmacokinetics and clinical experience ⬇️

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia

Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia

Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.

Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major

Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis

Investigating the Alpha1 Nco I Mutation

Liver iron concentrations and urinary hepcidin in beta-thalassemia

Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment

Natural history of hepatitis C in thalassemia major: a long-term prospective study

New case of contiguous gene syndrome at chromosome 8p11.2p12

No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia

Once-daily oral deferasirox for the treatment of transfusional iron overload

Onset of cardiac iron loading in pediatric patients with thalassemia major.

Osteoporosis in beta-thalassemia: Clinical and genetic aspects

Pregnancy and beta-thalassemia: an Italian multicenter experience.

Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study

Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major

Sudden cardiac failure in a β-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia

Thalassemia Major: Who Is Afraid of Serum Ferritin below 500 μg/l?

Thalassemia major between liver and heart: Where we are now.

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

α-globin gene quadruplication and heterozygous β-thalassemia: a not so rare cause of thalassemia intermedia

β-Thalassemia.